Amerisource Health Services LLC recalls Sucralfate Tablets
- Published
- 22 Oct 2025
- Units affected
- 27,868 blister packs
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]
- Brand / company
- Amerisource Health Services LLC
- Codes / lots
- Lot #: 1017392, Exp. Date 01/31/2026; 1017415, Exp. Date 12/31/2025.
- Distribution
- Nationwide within the United States
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 22 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.